Abstract
A total of 134 episodes of staphylococcal bacteremia (SBE) appearing among 9987 admissions, and 979 episodes of bacteremia in cancer patients within 5 years, were analyzed for risk factors, clinical course and outcome; 64 were monomicrobial and 70 polymicrobial. The most frequent risk factors were acute leukemia, catheter insertion, long-lasting neutropenia, and prior prophylaxis with quinolones. There was no significant difference between polymicrobial and monomicrobial SBE in risk factors. The two groups differed only in the source of bacteremia (gastrointestinal and respiratory-tract infections were more common in monomicrobial SBE) and etiology —Staphylococcus aureus appeared more frequently in monomicrobial than in polymicrobial bacteremia (20.3% compared to 4.3%,P<0.05). More complications (14.3%) such as abscesses, endocarditis, etc. appeared in the group of polymicrobial SBE (P < 0.05). No difference was observed in clinical course and outcome between monomicrobial and polymicrobial SBE. The incidence of SBE has increased since 1991, when quinolones were first used in prophylaxis in afebrile neutropenia at our center; however, the infection-associated mortality in monomicrobial SBE was low (4.3%).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arduino RC, Murray B (1993) Vancomycin-resistance in gram-positive organisms. Curr Opinion Infect Dis 6:715–724
Carratala J, Alcaide F, Fernandez-Sevilla A, Corbella X, Linares J, Guidal F (1995) Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis 20:1169
Chow J, Fine MJ, Shlaes DM, Quinn MD, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Infect Med 115:585
Conboy C, Welage LS, Walawander C (1995) Sepsis-syndrome and associated sequellae in patients at high risk for gram-negative sepsis. Pharmacoepidemiology 15:66
Durand B, Leclereq R, Pipau F, Cordonnier C (1995) Evolution of bacterial susceptibility to antibiotics during a six year period in a hematology unit. J Hosp Infect 29:19–33
Edmond MB, Ober J, Weinbaum DL, Pfaller MA, Wenzel RP (1995) Vancomycine-resistantE. faecium bacteremia: risk factors for infection. Clin Infect Dis 20:1126
EORTC Antimicrobial Therapy Cooperative Group (1992) Pefloxacin plus penicillin in prevention of infections in granulocytopenic patients. A randomized placebo-controlled trial. Abstracts of the 31th ICAAC, Anaheim, abstract 1543
EORTC Antimicrobial Study Group (1993) Gram-positive bacteremia in cancer patients from studies on empiric therapy of fever and neutropenia. Eur J Clin Microbiol Infect Dis 10:366
Cometta A, the EORTC Antimicrobial Therapy Cooperative Group (1995) Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 39:445–452
EORTC Antimicrobial Therapy Cooperative Group (1993) Amikacin plus ceftriaxone once daily versus in multiple daily doses in empiric therapy for febrile granulocytopenic patients. Ann Intern Med 119:584–593
Cometta A, the EORTC International Antimicrobial Therapy Cooperative Group and the GIMMEMA Programme (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 40:1108–1115
Fergie J, Shema S, Lott L, Crawford R, Patrick C (1994)Pseudomonas aeruginosa bacteremia in immunocompromised children. Clin Infect Dis 18:390
Hughes W, the IDSA Ad hoc Working Committee (1990) Guidelines for empiric therapy of febrile neutropenia in cancer patients. J Infect Dis 33:118
Lecciones JA, Lee JW, Navarro EE, Witebsky FG, Marshall D, Steinberg SM, Pizzo P, Walsh TJ (1992) Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 14:875–882
Montecalvo M, Horowitz H, Gedris C, Carbonaro C, Wormser GP (1994) Outbreak of VAN-resistantE. faecium bacteremia in an adult oncology unit. Antimicrob Agens Chemother 38:1363
Rosenthal D (1993) Epidemiology of microorganisms causing septicaemia. Dtsch Med Wochenschr 118:1270
Trupl J, Kunova A, Krcmery V Jr (1995) Bacteremia due to teicoplanin-resistantS. haemolyticus in neutropenic patients. Acta Chemother 3:72
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kukuckova, E., Spanik, S., Ilavska, I. et al. Staphylococcal bacteremia in cancer patients: Risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Support Care Cancer 4, 427–434 (1996). https://doi.org/10.1007/BF01880640
Issue Date:
DOI: https://doi.org/10.1007/BF01880640